E. Ohman J:Or Asset Management Ab Amgen Inc Transaction History

E. Ohman J:Or Asset Management Ab

$4.04 Trillion
Q3 2024

A detailed history of E. Ohman J:Or Asset Management Ab transactions in Amgen Inc stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 21,750 shares of AMGN stock, worth $5.73 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

21,750

Previous 22,950 5.23%

Holding current value

$5.73 Million

Previous $7.17 Billion 2.27%

% of portfolio

0.17%

Previous 0.18%

62 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$309.38 - $337.38 $371,256 - $404,856	-1,200 Reduced 5.23%	21,750 $7.01 Billion
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $302,162 - $367,206	1,150 Added 5.28%	22,950 $7.17 Billion
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $241,983 - $292,104	900 Added 4.31%	21,800 $6.2 Billion
Q4 2023 Feb 15, 2024	SELL	$255.7 - $288.46 $843,810 - $951,917	-3,300 Reduced 13.64%	20,900 $6.02 Billion
Q3 2023 Feb 06, 2024	BUY	$218.65 - $271.46 $5.29 Million - $6.57 Million	24,200 New	24,200 $6.5 Billion
Q2 2023 Apr 05, 2024	BUY	$214.27 - $253.37 $107,135 - $126,685	500 Added 2.07%	24,600 $5.46 Billion
Q1 2023 Apr 05, 2024	BUY	$225.79 - $275.2 $316,106 - $385,280	1,400 Added 6.17%	24,100 $5.83 Billion
Q4 2022 Apr 05, 2024	SELL	$229.03 - $291.01 $183,224 - $232,808	-800 Reduced 3.4%	22,700 $5.96 Billion
Q3 2022 Apr 05, 2024	SELL	$224.46 - $253.15 $291,798 - $329,095	-1,300 Reduced 5.24%	23,500 $5.3 Billion
Q2 2022 Apr 05, 2024	SELL	$230.71 - $256.74 $299,923 - $333,762	-1,300 Reduced 4.98%	24,800 $6.03 Billion
Q1 2022 Apr 05, 2024	SELL	$219.27 - $242.57 $350,832 - $388,112	-1,600 Reduced 5.78%	26,100 $6.31 Billion
Q4 2021 Apr 05, 2024	BUY	$198.88 - $227.6 $278,432 - $318,640	1,400 Added 5.32%	27,700 $6.23 Billion
Q3 2021 Apr 05, 2024	BUY	$212.27 - $248.7 $275,951 - $323,310	1,300 Added 5.2%	26,300 $5.59 Billion
Q2 2021 Apr 05, 2024	BUY	$233.58 - $259.14 $513,876 - $570,108	2,200 Added 9.65%	25,000 $6.09 Billion
Q1 2021 Apr 05, 2024	SELL	$221.91 - $258.6 $687,921 - $801,660	-3,100 Reduced 11.97%	22,800 $5.67 Billion
Q4 2020 Apr 05, 2024	BUY	$216.38 - $257.67 $367,846 - $438,039	1,700 Added 7.02%	25,900 $5.95 Billion
Q3 2020 Apr 05, 2024	BUY	$234.65 - $260.95 $398,905 - $443,615	1,700 Added 7.56%	24,200 $6.15 Billion
Q2 2020 Apr 05, 2024	BUY	$197.81 - $242.74 $257,153 - $315,562	1,300 Added 6.13%	22,500 $5.31 Billion
Q1 2020 Apr 05, 2024	SELL	$182.24 - $241.7 $1.59 Million - $2.1 Million	-8,700 Reduced 29.1%	21,200 $4.3 Billion
Q4 2019 Apr 05, 2024	BUY	$189.21 - $243.2 $529,788 - $680,960	2,800 Added 10.33%	29,900 $7.21 Billion
Q3 2019 Apr 05, 2024	BUY	$174.11 - $208.62 $139,288 - $166,896	800 Added 3.04%	27,100 $5.24 Billion
Q2 2019 Apr 05, 2024	SELL	$166.7 - $195.41 $16,670 - $19,541	-100 Reduced 0.38%	26,300 $4.85 Billion
Q1 2019 Apr 05, 2024	BUY	$180.87 - $203.88 $1.36 Million - $1.53 Million	7,500 Added 39.68%	26,400 $5.02 Billion
Q4 2018 Apr 05, 2024	SELL	$178.4 - $208.25 $410,320 - $478,975	-2,300 Reduced 10.85%	18,900 $3.68 Billion
Q3 2018 Apr 05, 2024	SELL	$185.29 - $208.89 $55,587 - $62,666	-300 Reduced 1.4%	21,200 $4.39 Billion
Q2 2018 Apr 05, 2024	BUY	$166.05 - $186.51 $1.05 Million - $1.18 Million	6,300 Added 41.45%	21,500 $3.97 Billion
Q1 2018 Apr 05, 2024	SELL	$169.43 - $198.0 $406,632 - $475,200	-2,400 Reduced 13.64%	15,200 $2.59 Billion
Q4 2017 Apr 05, 2024	SELL	$168.79 - $188.59 $270,064 - $301,744	-1,600 Reduced 8.33%	17,600 $3.06 Billion
Q3 2017 Apr 05, 2024	BUY	$167.29 - $191.0 $66,916 - $76,400	400 Added 2.13%	19,200 $3.58 Billion
Q2 2017 Apr 05, 2024	SELL	N/A	-700 Reduced 3.59%	18,800 $3.24 Billion
Q1 2017 Apr 05, 2024	BUY	N/A	1,700 Added 9.55%	19,500 $3.2 Billion
Q4 2016 Apr 05, 2024	BUY	N/A	1,700 Added 10.56%	17,800 $2.6 Billion
Q3 2016 Apr 05, 2024	BUY	N/A	1,500 Added 10.27%	16,100 $2.69 Billion
Q2 2016 Apr 05, 2024	BUY	N/A	700 Added 5.04%	14,600 $2.22 Billion
Q1 2016 Apr 05, 2024	SELL	N/A	-800 Reduced 5.44%	13,900 $2.08 Billion
Q4 2015 Apr 05, 2024	BUY	N/A	600 Added 4.26%	14,700 $2.39 Billion
Q3 2015 Apr 05, 2024	SELL	N/A	-1,600 Reduced 10.19%	14,100 $1.95 Billion
Q2 2015 Apr 05, 2024	SELL	N/A	-1,000 Reduced 5.99%	15,700 $2.41 Billion
Q1 2015 Apr 05, 2024	BUY	N/A	800 Added 5.03%	16,700 $2.67 Billion
Q4 2014 Apr 05, 2024	SELL	N/A	-1,000 Reduced 5.92%	15,900 $2.55 Billion
Q1 2014 Apr 05, 2024	SELL	N/A	-1,800 Reduced 9.63%	16,900 $2.08 Billion
Q4 2013 Apr 05, 2024	SELL	N/A	-400 Reduced 2.09%	18,700 $2.16 Billion
Q3 2013 Apr 05, 2024	BUY	N/A	1,100 Added 6.11%	19,100 $2.14 Billion
Q2 2013 Apr 05, 2024	SELL	N/A	-3,400 Reduced 15.89%	18,000 $1.78 Billion
Q1 2013 Apr 05, 2024	BUY	N/A	1,300 Added 6.47%	21,400 $2.19 Billion
Q4 2012 Apr 05, 2024	BUY	N/A	1,300 Added 6.91%	20,100 $1.73 Billion
Q2 2012 Apr 05, 2024	SELL	N/A	-2,900 Reduced 13.36%	18,800 $1.37 Billion
Q1 2012 Apr 05, 2024	BUY	N/A	5,900 Added 37.34%	21,700 $1.47 Billion
Q4 2011 Apr 05, 2024	SELL	N/A	-1,500 Reduced 8.67%	15,800 $1.01 Billion
Q3 2011 Apr 05, 2024	SELL	N/A	-3,600 Reduced 17.22%	17,300 $951 Million
Q1 2011 Apr 05, 2024	BUY	N/A	4,900 Added 30.63%	20,900 $1.12 Billion
Q4 2010 Apr 05, 2024	SELL	N/A	-1,300 Reduced 7.51%	16,000 $878 Million
Q2 2010 Apr 05, 2024	BUY	N/A	1,700 Added 10.9%	17,300 $910 Million
Q1 2010 Apr 05, 2024	BUY	N/A	1,300 Added 9.09%	15,600 $933 Million
Q4 2009 Apr 05, 2024	SELL	N/A	-2,800 Reduced 16.37%	14,300 $809 Million
Q2 2009 Apr 05, 2024	BUY	N/A	3,100 Added 22.14%	17,100 $905 Million
Q4 2008 Apr 05, 2024	BUY	N/A	2,100 Added 17.65%	14,000 $809 Million
Q3 2008 Apr 05, 2024	SELL	N/A	-3,300 Reduced 21.71%	11,900 $705 Million
Q2 2008 Apr 05, 2024	BUY	N/A	4,500 Added 42.06%	15,200 $717 Million
Q4 2007 Apr 05, 2024	BUY	N/A	1,350 Added 14.44%	10,700 $497 Million
Q1 2007 Apr 05, 2024	SELL	N/A	-350 Reduced 3.61%	9,350 $522 Million
Q4 2006 Apr 05, 2024	SELL	N/A	-11,200	9,700 $663 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.

Account

E. Ohman J:Or Asset Management Ab Amgen Inc Transaction History